Title : Molecular Mechanisms and Therapeutics for SCA17.

Pub. Date : 2019 Oct

PMID : 31317427






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Spinocerebellar ataxia type 17 (SCA17) is caused by polyglutamine (polyQ) expansion in the TATA box-binding protein (TBP), which functions as a general transcription factor. polyglutamine ataxin 7 Homo sapiens
2 Spinocerebellar ataxia type 17 (SCA17) is caused by polyglutamine (polyQ) expansion in the TATA box-binding protein (TBP), which functions as a general transcription factor. polyglutamine ataxin 7 Homo sapiens
3 Spinocerebellar ataxia type 17 (SCA17) is caused by polyglutamine (polyQ) expansion in the TATA box-binding protein (TBP), which functions as a general transcription factor. polyglutamine ataxin 7 Homo sapiens
4 Spinocerebellar ataxia type 17 (SCA17) is caused by polyglutamine (polyQ) expansion in the TATA box-binding protein (TBP), which functions as a general transcription factor. polyglutamine ataxin 7 Homo sapiens
5 Like other polyQ expansion-mediated diseases, SCA17 is characterized by late-onset and selective neurodegeneration, despite the disease protein being ubiquitously expressed in the body. polyglutamine ataxin 7 Homo sapiens
6 The well-characterized function of TBP and typical neurodegeneration in SCA17 give us opportunities to understand how polyQ expansion causes selective neurodegeneration and to develop effective therapeutics. polyglutamine ataxin 7 Homo sapiens